GOSS (Gossamer Bio, Inc.) Forward P/E Multiple
Gossamer Bio, Inc. (GOSS) is a recognized scientific innovator in pulmonary hypertension therapy. The company's forward P/E NTM visualizes market expectations, where the 0.00 metric determines the status of the valuation parameter. This trend reflects the impeccable state of R&D pipelines, although it is accompanied by significant risks of trial failure and a dependence on external financing due to a lack of profitability.
Analytical breakdowns for Gossamer Bio, Inc.
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
GOSS - Company Net Income|Expected Profit Gossamer Bio, Inc.|GOSS - Business Payback Period|Future Price to Earnings Gossamer Corp|GOSS - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Gossamer Bio Inc|GOSS - Operating profit EBITDA|Earnings per share for the last twelve months Gossamer Bio|GOSS - Net earnings per share for the last 12 months|Quarterly EPS earnings growth gossamerbio.com|GOSS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Gossamer Bio, Inc.
Summary company analytics:Gossamer Bio
For Gossamer Bio, Inc. (GOSS), the expected profits from seralutinib drive the company's market valuation. The forward P/E measures the premium for future growth by relating current market capitalization to projected earnings. By analyzing the company's forward P/E history, an investor can gauge the extent of expectations priced in for Phase 3 trials. A peer comparison reveals the business's technological advantage. The metric's trend confirms the investment attractiveness within the context of the partnership with Chiesi.
Competitors of Gossamer Bio, Inc. (GOSS)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings ADMA Corp (ADMA)|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|Kiniksa (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols SA|Projected Price to Earnings ADPT|Forward P/E Multiple Celldex Corp|Future Price to Earnings Aurinia Pharmaceuticals (AUPH)|biocryst.com - Price to Future Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Projected Price to Earnings Ratio|Pharvaris Corp - Forward P/E Multiple|Forward Price to Earnings Multiple AbCellera Biologics (ABCL)|Tourmaline Bio, Inc. (TRML) - Future Price to Earnings|Projected Price to Earnings Ratio precigen.com (PGEN)|Future Price to Earnings Pharming Group|Nektar Therapeutics Inc (NKTR) - Market Cap to Projected Earnings|Future Price to Earnings Upstream Bio Corp (UPB)|Market Cap to Projected Earnings Zenas Corp|Forward P/E Multiple IMNM (Immunome, Inc.)|Forward P/E Multiple kalvista.com KALV|SEPN - Future Price to Earnings|Pieris Pharma (PVLA) - Projected Price to Earnings|SVRA: Forward P/E Multiple|Projected Price to Earnings Ratio Rigel Corp (RIGL)|Future Price to Earnings AnaptysBio, Inc.|ATXS: Future Price to Earnings Multiple|Projected Price to Earnings ENGN (enGene)|RAPT (RAPT Therapeutics Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple JBIO (Aerovate Therapeutics)|Aclaris Therapeutics, Inc - Future Price to Earnings|Kyverna Therapeutics - Forward P/E Multiple|Market Cap to Projected Earnings tizianalifesciences.com TLSA|Cabaletta Bio (CABA) - Future Price to Earnings|Projected Price to Earnings Ratio Ventyx Biosciences Inc. (VTYX)|Projected Price to Earnings THTX|AVTX: Future Price to Earnings Multiple|Forward P/E Multiple ELDN|Market Cap to Projected Earnings agenusbio.com|Future Price to Earnings Climb Bio CLYM|ZURA: Price to Future Earnings Ratio|aTyr - Forward P/E Multiple|Adagene (ADAG) - Projected Price to Earnings|IMA (ikenaoncology.com) - Projected Price to Earnings|STTK - Market Cap to Projected Earnings|EQ (Equillium Inc) - Forward P/E Multiple|CNTB - Forward Price to Earnings Multiple|Future Price to Earnings Immunic, Inc. (IMUX)|ATRA - Projected Price to Earnings Ratio|Future Price to Earnings InflaRx IFRX|Market Cap to Projected Earnings x4pharma.com (XFOR)|ACET - Future Price to Earnings|Market Cap to Projected Earnings Celularity Inc. CELU|INmune Bio Corp (INMB) - Future Price to Earnings|Price to Expected Earnings Ratio BRNS (Barinthus Biotherapeutics Corp)|KZR (Kezar Life Sciences) - Forward P/E Multiple|SABS: Future Price to Earnings Multiple|Forward P/E Multiple AKTX|Forward P/E Multiple enlivex.com (ENLV)|Future Price to Earnings Q32 Bio QTTB|Future Price to Earnings Multiple GOVX|EDSA - Future Price to Earnings|ibioinc.com (IBIO) - Projected Price to Earnings|CARM: Forward P/E Multiple|XTL Biopharmaceuticals Ltd (XTLB) - Forward P/E Multiple|Projected Price to Earnings BOLT|HCWB: Future Price to Earnings Multiple|Forward P/E Multiple APVO|Market Cap to Projected Earnings AIM ImmunoTech, Inc.|Future Price to Earnings Aditxt, Inc. ADTX|GRI - Projected Price to Earnings|XRTX - Future Price to Earnings|Vyome Therapeutics (HIND) - Projected Price to Earnings|REVB (Revelation Biosciences) - Projected Price to Earnings|indaptusrx.com (INDP) - Forward P/E Multiple|Future Price to Earnings Scinai Immunotherapeutics Ltd.|Price to Future Earnings Ratio CALI (CalciMedica Corp)|Forward P/E Multiple AFMD|ALLK - Projected Price to Earnings Ratio|Forward P/E Multiple HOOK (HOOKIPA Pharma)|Forward Price to Earnings Multiple IGM Biosciences Inc.|ITOS - Future Price to Earnings|Projected Price to Earnings Ratio Ocean Biomedical Inc|TC BioPharm (Holdings) PLC (TCBP) - Future Price to Earnings|THRD - Market Cap to Projected Earnings
